Encompass Health Corporation

EHC Healthcare Medical Care Facilities

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.

Revenue
+8.93%
EPS
+20.6%
Free cash flow
+52.3%
Total debt
+6.83%

Quarter to September 2026, against a year earlier

137.50 3.77 −2.67%
Market cap
$13.9B
P/E
21.8×
Fwd P/E
20.9×
Dividend yield
0.55%
F-score
7/9
Altman Z
3.25
Beneish M
−2.71
Dividend safety
77/100

Encompass Health Corporation (EHC) EBITDA

Alert me on EBITDA

Encompass Health Corporation's EBITDA for fiscal 2025 was $1.4B, up 18.5% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.5B. Over the past ten years it has ranged from $678.3M (fiscal 2015) to $1.4B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. Encompass Health Corporation ranks 7th of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $1.4B 18.53%
FY2024 $1.2B 15.56%
FY2023 $1.0B 14.91%
FY2022 $883.5M (0.26%)
FY2021 $885.8M 20.44%
FY2020 $735.5M (19.00%)
FY2019 $908.0M 8.96%
FY2018 $833.3M 0.25%
FY2017 $831.2M (0.48%)
FY2016 $835.2M 23.13%

Quarterly newest first

Period EBITDA Change
Sep 2026 $383.7M 2.16%
Jun 2026 $375.6M (3.37%)
Mar 2026 $388.7M 2.45%
Dec 2025 $379.4M 16.38%
43 more quarters

Against its own ten years

Low $678.3M High $1.4B
Ten-year median $883.5M
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on EHC